HS-20137

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-20137, covering 2025-02-25 to 2025-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis [Phase 3]